Renal dysfunction among HIV-infected patients starting antiretroviral therapy. - Wikidata - awgldk - TriplyDB

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

http://www.wikidata.org/entity/Q36781012

about

Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events Risk factors for impaired fasting glucose or diabetes among HIV infected patients on ART in the Copperbelt Province of Zambia.Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study.The influence of HIV and schistosomiasis on renal function: a cross-sectional study among children at a hospital in Tanzania Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.Prevalence of persistent microalbuminuria and associated factors among HIV infected children attending a Tertiary Hospital in Northern Tanzania: a cross sectional, analytical study.HAART, DOTS and renal disease of patients co-infected with HIV/AIDS and TB in the South West Region of Cameroon.Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens Update on tenofovir toxicity in the kidney.Determinants of uncontrolled hypertension among clients on anti-retroviral therapy in Kadoma City, Zimbabwe, 2016.Dipstick urinalysis should be documented prior to initiating antiretroviral therapy HIV-associated nephropathy in Saudi Arabia.Renal manifestations of HIV during the antiretroviral era in South Africa: a systematic scoping review.Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa.Kidney Disease in HIV-Infected Persons.Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review.Effect of Tenofovor Diproxil Fumarate on Renal Function and Urinalysis Abnormalities in HIV-Infected Cameroonian Adults.Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis.Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania.

P2860

Q28535587-C07756D3-A90E-4B15-8D0D-5D18450F5D71 Q33910561-5A39E8ED-4A92-4C31-9C78-AB9EB2581AD1 Q34568454-A58163C8-34BA-4363-AFF3-4A905A7EA8CF Q35001172-BFDD5953-88F9-4156-9415-E27357063A79 Q35042534-2A355D45-A192-4AFE-8AF6-C9147ABAFC70 Q35107651-A2B46904-AFB4-43DA-B49F-7F3F750C55D4 Q35149475-26B505AF-EC46-49BE-80E3-5E54063AFAA9 Q35789701-0E5EB805-4E85-473A-B4DD-BF77D34457D0 Q35802060-F5A2A765-C7AA-482A-AC12-A9FFD0B93FA0 Q35858002-0F130E9A-A45D-42D2-B33F-E8494F78FA33 Q36106860-43AB2EAC-C59E-4625-A0E1-5A0C51169654 Q36388998-50F50D82-2694-4129-B77B-D4C1E371A68D Q37263602-344E5446-DB7E-4DB6-938C-6F8F85B97489 Q38033446-7390638D-67CA-48AC-BC33-B6EC8C4C5212 Q38687250-EFEB4C9C-2559-45C3-BA03-3DFC1C2F143F Q42101103-4956AFDA-0CFF-4E89-8829-BD33EB7D9163 Q42267516-1BC6EBCA-7624-4804-8333-55578CB7793E Q42377428-75759740-9797-45A8-90C5-FE764BD12996 Q42539731-86A9A837-5276-4E48-A767-FD69E6989DF3 Q46653347-27C5B26A-AA9F-4748-AA4E-D2EDA4B8396B Q47736998-3204F58E-5A76-4BBF-BFB6-69208E48DCAB Q50001717-13C0FBCA-5D38-4BC1-BC05-B09B4313DF46 Q50348041-E2F4CDB8-317B-43C1-B64E-7F12A583242A Q53692625-B00703FA-6183-4CA5-8E96-8E2CE06D58A5 Q53758268-8A41E30C-B866-4D6C-9459-63870F9296C5

P2860

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

http://www.wikidata.org/entity/Q36781012

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

@ast

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

@en

type

label

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

@ast

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

@en

prefLabel

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

@ast

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

@en

P1433

Q36781012-4F3F2F7A-459C-4813-BF20-4A2D26DAB688

P1476

Q36781012-38CB85E8-014B-4225-B685-FB634F3FDD82

P2093

Q36781012-BDB89D42-A745-4121-BF5E-4F134430EF6F

Q36781012-C016E57B-1561-40A1-B763-C8153559BF6D

Q36781012-C5783C9E-83FE-48C5-AF1A-042A5112D603

Q36781012-DA5DC884-9D30-414E-BD16-DAB26E7A8C84

Q36781012-E59CF0F6-717B-4F35-A5EF-044318A96EE6

Q36781012-ED56EF8D-0D51-4E45-9927-F27486112BC6

Q36781012-F1135DCC-8620-4C25-BA5C-96F4C50B5CC4

P2860

Q36781012-0AFCE053-9A39-468A-BC3C-191F55E811AA

Q36781012-0F202F4A-FDE6-47A4-A321-90FC6D01996E

Q36781012-2CFC7F62-0FA3-484A-90E4-7DC48BEDDAA3

Q36781012-2DC8C2A1-0AA9-45A8-8F7C-D7BD6990824E

Q36781012-8D587358-7DB2-40A6-9B8C-0824372CDB41

Q36781012-A325B3F2-7941-4ED4-BE36-6F92C44FF7D4

Q36781012-A9629B8E-4A53-48B5-AF1A-637FF7CF09C3

Q36781012-AC6E1634-0BCA-40AA-A666-124ECF99582B

Q36781012-BA4018AF-7148-4CE4-BB77-DC181F110069

Q36781012-CCAE2C93-22BC-479F-AFFB-BFAA39A6059D

P304

Q36781012-5823C3F4-6646-4292-AA96-138054A23F2D

P31

Q36781012-B0E2E5B1-1E02-44E6-A665-C33441344329

P356

Q36781012-EAE9B86C-4587-4328-BA6E-4E43B5C3D72E

P407

Q36781012-D0C60342-06D7-4290-870B-69330E111726

P433

Q36781012-D4CED537-5C84-4B3F-8BD0-7F597AA4ABFF

P478

Q36781012-B787DC51-5D93-4C2C-A477-B849CF7407FD

P50

Q36781012-1595AA33-C9E3-4A2B-B0DD-E94519E482CB

P577

Q36781012-56F1CA1A-6A8E-407E-9EB9-242F5EC56446

P698

Q36781012-204F8C7F-9C90-4947-B4CA-A048732A4EE9

P921

Q36781012-5D35999B-FBD7-4AA9-9C29-808C95977C73

P932

Q36781012-5DF8B548-8511-40FB-B877-FA9E4AD9B562

P356

QAD.0B013E328348A4B1

P1433

P1476

Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

@en

P2093

Benson R Kidenya

http://www.w3.org/2001/XMLSchema#string

Jennifer A Downs

http://www.w3.org/2001/XMLSchema#string

Leonard Msango

http://www.w3.org/2001/XMLSchema#string

Robert N Peck

http://www.w3.org/2001/XMLSchema#string

Rodrick Kabangila

http://www.w3.org/2001/XMLSchema#string

Samuel E Kalluvya

http://www.w3.org/2001/XMLSchema#string

Warren D Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia.

Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae.

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.

Fanconi syndrome and renal failure induced by tenofovir: a first case report.

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.

Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya.

P304

1421-1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E328348A4B1

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Daniel W Fitzgerald

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21572304

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3631352

http://www.w3.org/2001/XMLSchema#string